Related references
Note: Only part of the references are listed.RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch et al.
CLINICAL INFECTIOUS DISEASES (2020)
Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli
Ngel Rodriguez-Villodres et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
The Global Ascendency of OXA-48-Type Carbapenemases
Johann D. D. Pitout et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Structural Insight into the Mechanism of Inhibitor Resistance in CTXM-199, a CTX-M-64 Variant Carrying the S130T Substitution
Qipeng Cheng et al.
ACS INFECTIOUS DISEASES (2020)
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019
Lara Tavoschi et al.
EUROSURVEILLANCE (2020)
Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis
Parichehr Shamsrizi et al.
BMJ OPEN (2020)
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
Matteo Bassetti et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales
Antonio Vena et al.
ANTIBIOTICS-BASEL (2020)
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2019)
A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2019)
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wenjing Wu et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel et al.
DRUGS (2019)
Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview
Roberto Vivas et al.
MICROBIAL DRUG RESISTANCE (2019)
Interplay between β-lactamases and new β-lactamase inhibitors
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2019)
The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China
Huixue Jia et al.
BIOMED RESEARCH INTERNATIONAL (2019)
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Catherine L. Tooke et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase
Clyde A. Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Gradual in vitro Evolution of Cefepime Resistance in an ST131 Escherichia coli Strain Expressing a Plasmid-Encoded CMY-2 β-Lactamase
Valentina Dona et al.
FRONTIERS IN MICROBIOLOGY (2019)
CTX-M-33 Is a CTX-M-15 Derivative Conferring Reduced Susceptibility to Carbapenems
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options
Gisele Peirano et al.
DRUGS (2019)
The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop
Antonela R. Palacios et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Crystal structures of VIM-1 complexes explain active site heterogeneity in VIM-class metallo-β-lactamases
Ramya Salimraj et al.
FEBS JOURNAL (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Beatriz Suay-Garcia et al.
ANTIBIOTICS-BASEL (2019)
Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli
Ahmed A. Ramadan et al.
SCIENTIFIC REPORTS (2019)
Diversity of Carbapenemase-Producing Escherichia coil Isolates in France in 2012-2013
Lauraine Gauthier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Current epidemiology, genetic evolution and clinical impact of extendedspectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Yong Chong et al.
INFECTION GENETICS AND EVOLUTION (2018)
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Eili Y. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases
Sadeeq Ur Rahman et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017
Kate Russell Woodworth et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis
Amber Martin et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Past and Present Perspectives on β-Lactamases
Karen Bush
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial
Patrick N. A. Harris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections
Mario Tumbarello et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2018)
Synergistic effects of functionally distinct substitutions in -lactamase variants shed light on the evolution of bacterial drug resistance
Meha P. Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics
Zhizeng Sun et al.
NATURE COMMUNICATIONS (2018)
Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
Hayley Wilson et al.
MICROBIAL GENOMICS (2018)
Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins
Catherine Branger et al.
MICROBIAL GENOMICS (2018)
Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases
Timothy Palzkill
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Complete Nucleotide Sequence of an Escherichia coli Sequence Type 410 Strain Carrying bla(NDM-5) on an IncF Multidrug Resistance Plasmid and bla(OXA-181) on an IncX3 Plasmid
Seren Overballe-Petersen et al.
GENOME ANNOUNCEMENTS (2018)
Inventory of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study
F. Robin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate
Zhen Shen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China
Jingjing Quan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin et al.
VIRULENCE (2017)
β-Lactamases: A Focus on Current Challenges
Robert A. Bonomo
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Emergence of carbapenem resistant Escherichia coli isolates producing blaNDM and blaOXA-48-like carried on IncA/C and IncL/M plasmids at two Iranian university hospitals
Hamid Solgi et al.
INFECTION GENETICS AND EVOLUTION (2017)
Carbapenem-resistant Enterobacteriaceae in the community: a scoping review
Ana M. Kelly et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extendedspectrum- β-lactamase-producing Enterobacteriaceae
Zaira Raquel Palacios-Baena et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
Edward R. Bevan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Genomic epidemiology of global VIM-producing Enterobacteriaceae
Yasufumi Matsumura et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting
Patrick Musicha et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Beta-lactamase database (BLDB) - structure and function
Thierry Naas et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Latania K. Logan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae
Esther Rios et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany
Michael Pietsch et al.
VETERINARY MICROBIOLOGY (2017)
The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis
Han Feng et al.
NATURE COMMUNICATIONS (2017)
Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis
Maged Muhammed et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
A novel Tn1696-like composite transposon (Tn6404) harboring blaIMP-4 in a Klebsiella pneumoniae isolate carrying a rare ESBL gene blaSFO-1
Kai Zhou et al.
SCIENTIFIC REPORTS (2017)
Occurrence of Clinically Important Lineages, Including the Sequence Type 131 C1-M27 Subclone, among Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Wastewater
Ryota Gomi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Genetic and Functional Characterization of blaCTX-M-199, a Novel Tazobactam and Sulbactam Resistance-Encoding Gene Located in a Conjugative mcr-1-Bearing IncI2 Plasmid
Jiachang Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Rapid Identification of Different Escherichia coli Sequence Type 131 Clades
Yasufumi Matsumura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation
Meha P. Patel et al.
BIOCHEMISTRY (2017)
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Carbapenem-Resistant Enterobacteriaceae
Alina Lovleva et al.
CLINICS IN LABORATORY MEDICINE (2017)
Spread from the Sink to the Patient: In Situ Study Using Green Fluorescent Protein (GFP)-Expressing Escherichia coli To Model Bacterial Dispersion from Hand-Washing Sink-Trap Reservoirs
Shireen Kotay et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)
Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health
Asad U. Khan et al.
BMC MICROBIOLOGY (2017)
Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective
J. A. Otter et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Mechanisms Involved in Acquisition of blaNDM Genes by IncA/C2 and IncFIIY Plasmids
Alexander M. Wailan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis
Wei Xin Khong et al.
BMC GENOMICS (2016)
The negative impact of antibiotic resistance
N. D. Friedman et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Structural and Functional Aspects of Class A Carbapenemases
Thierry Naas et al.
CURRENT DRUG TARGETS (2016)
B1-Metallo-beta-Lactamases: Where Do We Stand?
Maria F. Mojica et al.
CURRENT DRUG TARGETS (2016)
Emergence of KPC-producing Klebsiella pneumoniae hypervirulent clone of capsular serotype K1 that belongs to sequence type 11 in Mainland China
Dan-dan Wei et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli
B. Ghosh et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Identification of a novel IMI carbapenemase variant (IMI-9) in Enterobacter cloacae complex
Maria Chiara Di Luca et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48
Adriana Ortega et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Role of the Conserved Disulfide Bridge in Class A Carbapenemases
Clyde A. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Belen Gutierrez-Gutierrez et al.
MAYO CLINIC PROCEEDINGS (2016)
Interconnected microbiomes and resistomes in low-income human habitats
Erica C. Pehrsson et al.
NATURE (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous
Apostolos Liakopoulos et al.
FRONTIERS IN MICROBIOLOGY (2016)
First identification of NDM-5 associated with OXA-181 in Escherichia coli from Egypt
Doaa Gamal et al.
EMERGING MICROBES & INFECTIONS (2016)
Laboratory detection and clinical implication of oxacillinase-48 like carbapenemase: The hidden threat
Yamuna Devi Bakthavatchalam et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2016)
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime
Joao Pires et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Characterization of the Global Stabilizing Substitution A77V and Its Role in the Evolution of CTX-M β-Lactamases
Meha P. Patel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Avibactam and Inhibitor-Resistant SHV β-Lactamases
Marisa L. Winkler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Dominance of IMP-4-Producing Enterobacter cloacae among Carbapenemase-Producing Enterobacteriaceae in Australia
Hanna E. Sidjabat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Genetic Contexts of blaNDM-1 in Patients Carrying Multiple NDM-Producing Strains
Alexander M. Wailan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015
B. Albiger et al.
EUROSURVEILLANCE (2015)
Structural and biochemical characterization of VIM-26 shows that Leu224 has implications for the substrate specificity of VIM metallo-beta-lactamases
Hanna-Kirsti S. Leiros et al.
FEBS JOURNAL (2015)
Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance
Jeong Ho Jeon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
New plasmid-mediated aminoglycoside 6′-N-acetyltransferase, AAC(6′)-Ian, and ESBL, TLA-3, from a Serratia marcescens clinical isolate
Wanchun Jin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability
Shrenik C. Mehta et al.
PLOS PATHOGENS (2015)
Molecular Basis for the Catalytic Specificity of the CTX-M Extended-Spectrum β-Lactamases
Carolyn J. Adamski et al.
BIOCHEMISTRY (2015)
Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai
M. Kazi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Molecular mechanisms of antibiotic resistance
Jessica M. A. Blair et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Crystal Structure of Carbapenemase OXA-58 from Acinetobacter baumannii
Clyde A. Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
High Incidence and Endemic Spread of NDM-1-Positive Enterobacteriaceae in Henan Province, China
Shangshang Qin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
P. Nordmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
Ilker Inanc Balkan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third-or fourth-generation cephalosporins
Anette M. Hammerum et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Carbapenemase Genes among Multidrug Resistant Gram Negative Clinical Isolates from a Tertiary Hospital in Mwanza, Tanzania
Martha F. Mushi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
Laurent Dortet et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Class D β-Lactamases: A Reappraisal after Five Decades
David A. Leonard et al.
ACCOUNTS OF CHEMICAL RESEARCH (2013)
Metallo-beta-lactamase structure and function
Timothy Palzkill
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Proliferation and significance of clinically relevant β-lactamases
Karen Bush
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 US Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Structural Basis for Carbapenemase Activity of the OXA-23 β-Lactamase from Acinetobacter baumannii
Clyde A. Smith et al.
CHEMISTRY & BIOLOGY (2013)
Public Health Risks of Enterobacterial Isolates Producing Extended-Spectrum β-Lactamases or AmpC β-Lactamases in Food and Food-Producing Animals: An EU Perspective of Epidemiology, Analytical Methods, Risk Factors, and Control Options
Ernesto Liebana et al.
CLINICAL INFECTIOUS DISEASES (2013)
Community-Associated Extended-Spectrum β-Lactamase-Producing Escherichia coli Infection in the United States
Yohei Doi et al.
CLINICAL INFECTIOUS DISEASES (2013)
Molecular Characterization of an Atypical IncX3 Plasmid pKPC-NY79 Carrying bla KPC-2 in a Klebsiella pneumoniae
Pak-Leung Ho et al.
CURRENT MICROBIOLOGY (2013)
Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011
A Potron et al.
Eurosurveillance (2013)
CTX-M-type β-lactamases: A successful story of antibiotic resistance
Marco Maria D'Andrea et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Plasmids and the spread of resistance
Alessandra Carattoli
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2013)
In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy
H. Jacquier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria
Elizabeth M. H. Wellington et al.
LANCET INFECTIOUS DISEASES (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
Stormy waters ahead: global emergence of carbapenemases
Gopi Patel et al.
FRONTIERS IN MICROBIOLOGY (2013)
Multidrug resistant cornmensal Escherichia coli in animals and its impact for public health
Ama Szmolka et al.
FRONTIERS IN MICROBIOLOGY (2013)
Escherichia coli from Italy Producing OXA-48 Carbapenemase Encoded by a Novel Tn1999 Transposon Derivative
Tommaso Giani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Diverse Sequence Types of Klebsiella pneumoniae Contribute to the Dissemination of blaNDM-1 in India, Sweden, and the United Kingdom
Christian G. Giske et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
Sun Hee Park et al.
BMC INFECTIOUS DISEASES (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
OXA-48-like carbapenemases: the phantom menace
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Complete sequencing of an IncH plasmid carrying the blaNDM-1, blaCTX-M-15 and qnrB1 genes
Laura Villa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa
Adrian J. Brink et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
CTX-M enzymes: origin and diffusion
Rafael Canton et al.
FRONTIERS IN MICROBIOLOGY (2012)
Early Dissemination of NDM-1-and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons
Wei-Hua Zhao et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2011)
Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli
Wei-Hua Zhao et al.
FUTURE MICROBIOLOGY (2011)
High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination
Mi Young Lee et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Hydrolytic Mechanism of OXA-58 Enzyme, a Carbapenem-hydrolyzing Class D β-Lactamase from Acinetobacterbaumannii
Vidhu Verma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structural and Computational Investigations of VIM-7: Insights into the Substrate Specificity of VIM Metallo-β-Lactamases
Pardha Saradhi Borra et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Complete Sequencing of the blaNDM-1-Positive IncA/C Plasmid from Escherichia coli ST38 Isolate Suggests a Possible Origin from Plant Pathogens
Tsuyoshi Sekizuka et al.
PLOS ONE (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug-Resistant E. coli Infections in the United States
James R. Johnson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Structural Insights into Substrate Recognition and Product Expulsion in CTX-M Enzymes
Julien Delmas et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K. Kumarasamy et al.
LANCET INFECTIOUS DISEASES (2010)
MEROPS: the peptidase database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2010)
Reduced Susceptibility to Cefepime among Escherichia coli Clinical Isolates Producing Novel Variants of CMY-2 β-Lactamase
Yohei Doi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Dongeun Yong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Mutation of the Active Site Carboxy-Lysine (K70) of OXA-1 β-Lactamase Results in a Deacylation-Deficient Enzyme
Kyle D. Schneider et al.
BIOCHEMISTRY (2009)
Crystal Structure of the OXA-48 β-Lactamase Reveals Mechanistic Diversity among Class D Carbapenemases
Jean-Denis Docquier et al.
CHEMISTRY & BIOLOGY (2009)
Antibiotic resistance: the perfect storm
I.M. Gould
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 β-lactamase
David C. Marciano et al.
PROTEIN SCIENCE (2009)
Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
blaIMP-4 in different genetic contexts in Enterobacterzaceae isolates from Australia
Bjoern A. Espedido et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
IRT and CMT beta-lactamases and inhibitor resistance
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Minor extended-spectrum beta-lactamases
T. Naas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Clinically significant carbapenemases: an update
Timothy R. Walsh
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Extended-spectrum cephalosporinases: structure, detection and epidemiology
Patrice Nordmann et al.
FUTURE MICROBIOLOGY (2007)
Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis
Elena Santillana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: Importance of inadequate initial antimicrobial treatment
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The CTX-M β-lactamase pandemic
Rafael Canton et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
OXA-type carbapenemases
J Walther-Rasmussen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Ab initio QM/MM study of class A β-lactamase acylation:: Dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70
SO Meroueh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Amino acid residues that contribute to substrate specificity of class A β-lactamase SME-1
FK Majiduddin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Atomic resolution structures of CTX-M β-lactamases:: Extended spectrum activities from increased mobility and decreased stability
Y Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes
R Bonnet
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Identification of Glu166 as the general base in the acylation reaction of class A β-lactamases through QM/MM modeling
JC Hermann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Structural aspects for evolution of β-lactamases from penicillin-binding proteins
SO Meroueh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
On functional and structural heterogeneity of VIM-type metallo-β-lactamases
JD Docquier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs
XJ Wang et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Share Paper
